Sage Potash Closes Second and Final Tranche of Unit Offering
Sage TherapeuticsSage Therapeutics(US:SAGE) TMX Newsfile·2026-01-28 22:00

Core Viewpoint - Sage Potash Corp. has successfully closed a second tranche of its private placement financing, raising a total of $13,006,200 through the issuance of 65,031,000 units, which will be utilized for key project developments and working capital [1][2][3]. Financing Details - The second tranche involved the issuance of 7,595,000 units at a price of $0.20 per unit, generating gross proceeds of $1,519,000 [1]. - Each unit consists of one common share and one warrant, with each warrant allowing the purchase of one common share at $0.30 for three years [2]. Use of Proceeds - Proceeds from the offering will primarily fund the implementation of recommendations from RESPEC LLC's Preliminary Economic Assessment, including drilling and engineering reviews [3]. - Additional funds will be allocated for working capital and general administrative expenses [3]. Finder's Fees and Related Party Transactions - The company paid a total of $733,704 in cash fees, issued 90,000 common shares, and 3,749,520 finder's warrants as part of the offering [4]. - Certain insiders acquired a total of 6,025,000 units, which is classified as a related party transaction but is exempt from formal valuation and minority shareholder approval requirements [6]. Regulatory Approval - The TSX Venture Exchange has conditionally approved the offering, pending customary final filings [7]. Company Overview - Sage Potash Corp. is focused on developing its flagship Sage Plain Potash Project in the Paradox Basin, Utah, aiming to establish a sustainable domestic potash production platform [9].

Sage Potash Closes Second and Final Tranche of Unit Offering - Reportify